Pathogenic variants were identified in 11.8% (6/51) of male patients with breast cancer and were found in BRCA1, BRCA2, CHEK2, and PALB2; one man was positive for both a BRCA1 and CHEK2 variant. Here, BRCA2 is linked to breast carcinoma.